Home > Dáil Éireann debate. Written answer 225 – Cannabis for medicinal use [travel] [13439/22].

[Oireachtas] Dáil Éireann debate. Written answer 225 – Cannabis for medicinal use [travel] [13439/22]. (09 Mar 2022)

External website: https://www.oireachtas.ie/en/debates/question/2022...


225. Deputy Peter Burke asked the Minister for Health the conditions that are applied to a person travelling to Ireland with a prescribed cannabis-based medicinal product; and if he will make a statement on the matter. [13439/22] 

Stephen Donnelly, Minister for Health: In Ireland, cannabis and psychoactive cannabis derivatives (which includes tetrahydrocannabinol (THC)), are strictly controlled under Ireland’s national Misuse of Drugs Acts 1977 to 2016, and the Regulations and Orders made thereunder. Cannabis is listed in Schedule 1 of the Misuse of Drugs Regulations 2017, which means it is subject to the strictest level of control. Possession is unlawful except under licence. 

Under the legislation cannabis-based products containing THC are not permitted to be imported into Ireland, unless the product has been prescribed on an individual patient basis by an Irish registered medical practitioner subject to a Ministerial licence being granted to that prescriber pursuant to Section 14 of the Misuse of Drugs Act, or under licence for a product in Schedule 1 of S.I. No. 262/2019 - Misuse of Drugs (Prescription And Control Of Supply Of Cannabis For Medical Use) Regulations 2019.

Item Type
Dail Debates
Publication Type
International, Open Access, Article
Drug Type
Cannabis, Prescription/Over the counter
Intervention Type
Crime prevention, Policy
Date
9 March 2022
EndNote

Repository Staff Only: item control page